Eli Lilly and Company (LLY) Stock Split, History Data
Working capital analysis
In terms of working capital, Eli Lilly and Company maintains a healthy position.
The total current assets of the company are valued at $25727000000.
This represents a growth rate of 42.654% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $2818600000, exhibiting a growth rate of 36.362% year-on-year.
The receivables, another significant portion of the current assets, are valued at $11336200000.
The year-on-year growth rate for receivables is 32.449%.
The inventory, which forms a critical part of the assets, is valued at $5772800000.
This represents a healthy year-on-year growth of 33.949%
On the liabilities side, the company's current liabilities total $27293200000.
This reflects a growth rate of 59.254% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
2818.60
2067.00
3818.50
3657.10
2337.50
7320.70
Receavebles
11336.20
8558.90
8127.20
6929.00
5541.50
5776.80
Inventory
5772.80
4309.70
3886.00
3980.30
3190.70
3098.10
Other
149.50
2954.10
2530.60
2871.50
2538.90
2146.50
Total Current Assets
25727.00
18034.50
18452.40
17462.10
13709.60
20549.60
Acc Payable
2598.80
1930.60
1670.60
1606.70
1405.30
1207.10
Short Term Debt
6904.50
1501.10
1538.30
8.70
1499.30
1102.20
Other Current Liab
3281.30
13706.50
3027.50
2750.30
2189.40
9174.80
Current Liabilities
27293.20
17138.20
15052.70
12481.60
11775.20
11888.10
Capital Structure
When examining the capital structure of Eli Lilly and Company, it is clear that the company manages a robust portfolio.
The value of their total assets clocks in at $63943500000.
When juxtaposed with the previous year, this marks a growth rate of 20.278%, showcasing the company's ability to steadily grow its asset base.
Turning to liabilities, the company has total liabilities amounting to $51046100000.
Compared to the prior year, this reflects a growth rate of 21.921%.
The long-term debt forms a sizable part of these liabilities, coming in at $24559900000.
Over the last year, the long-term debt has grown by 30.081%.
On the asset side, the cash and equivalent reserves are worth $2460200000.
The year-on-year growth of these reserves is -30.618%.
The company's common stock, another important asset, holds a value of $594200000, growing at a rate of 0.118% from the previous year.
Finally, the company's retained earnings stand at $12553900000, marking a growth rate of 17.996% year-over-year.
These earnings represent the profits that Eli Lilly and Company has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$63,943.50
Total liabilities
$51,046,100,000.00
Long term debt
$24,559.90
Cash and eqv
$2,460,200,000.00
Goodwill
$4,939.60
Retained earnings
$12,553,900,000.00
Common stock
$0.00
Enterprise Value
$43.44
Historical dividend key summary
Eli Lilly and Company's dividend per share is $4.69, showing the earnings shared with shareholders per share. It has grown by -71.239% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years
Q1
Q2
Q3
Q4
Total
2024
1.300
0.000
0.000
0.000
1.300
2023
1.130
1.130
1.130
1.130
4.520
2022
0.980
0.980
0.980
0.980
3.920
2021
0.850
0.850
0.850
0.850
3.400
2020
0.740
0.740
0.740
0.740
2.960
2019
0.645
0.645
0.645
0.645
2.580
2018
0.563
0.563
0.563
0.563
2.250
2017
0.520
0.520
0.520
0.520
2.080
2016
0.510
0.510
0.510
0.510
2.040
2015
0.500
0.500
0.500
0.500
2.000
2014
0.490
0.490
0.490
0.490
1.960
2013
0.490
0.490
0.490
0.490
1.960
2012
0.490
0.490
0.490
0.490
1.960
2011
0.490
0.490
0.490
0.490
1.960
2010
0.490
0.490
0.490
0.490
1.960
2009
0.490
0.490
0.490
0.490
1.960
2008
0.470
0.470
0.470
0.470
1.880
2007
0.425
0.425
0.425
0.425
1.700
2006
0.400
0.400
0.400
0.400
1.600
2005
0.380
0.380
0.380
0.380
1.520
2004
0.355
0.355
0.355
0.355
1.420
2003
0.335
0.335
0.335
0.335
1.340
2002
0.310
0.310
0.310
0.310
1.240
2001
0.280
0.280
0.280
0.280
1.120
2000
0.260
0.260
0.260
0.260
1.040
1999
0.230
0.230
0.230
0.230
0.920
1998
0.200
0.200
0.200
0.200
0.800
1997
0.180
0.180
0.180
0.200
0.740
1996
0.171
0.171
0.171
0.171
0.685
1995
0.161
0.161
0.161
0.171
0.655
1994
0.156
0.156
0.156
0.156
0.625
1993
0.151
0.151
0.151
0.151
0.605
1992
0.138
0.138
0.138
0.138
0.550
1991
0.125
0.125
0.125
0.125
0.500
1990
0.102
0.102
0.102
0.102
0.410
1989
0.084
0.084
0.084
0.084
0.337
1988
0.072
0.072
0.072
0.072
0.287
1987
0.063
0.063
0.063
0.063
0.250
1986
0.056
0.056
0.056
0.056
0.225
1985
0.050
0.050
0.050
0.050
0.200
1984
0.045
0.045
0.045
0.050
0.186
1983
0.041
0.041
0.045
0.045
0.172
1982
0.041
0.041
0.041
0.041
0.163
1981
0.036
0.036
0.036
0.036
0.144
1980
0.033
0.033
0.036
0.036
0.138
1979
0.028
0.028
0.033
0.033
0.122
1978
0.025
0.025
0.025
0.028
0.103
1977
0.022
0.022
0.022
0.022
0.089
1976
0.019
0.019
0.020
0.020
0.078
1975
0.017
0.017
0.017
0.017
0.069
1974
0.015
0.015
0.016
0.016
0.061
1973
0.012
0.012
0.013
0.013
0.050
1972
0.000
0.000
0.011
0.011
0.023
Net earnings per share (EPS)
Eli Lilly and Company has an EPS of $2.49, which signifies the profit allocated per share of common stock. With a growth rate of -56.287% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years
Q1
Q2
Q3
Q4
Total
2024
2.49
-
-
-
2.49
2023
1.49
1.96
-0.0638
2.31
5.70
2022
2.11
1.06
1.61
2.04
6.82
2021
1.49
1.53
1.22
1.81
6.05
2020
1.6
1.56
1.33
2.21
6.70
2019
4.33
1.44
1.37
1.56
8.70
2018
1.16
-0.25
1.13
1.06
3.10
2017
-0.1
0.96
0.53
-1.59
-0.20
2016
0.42
0.71
0.74
0.7
2.57
2015
0.5
0.57
0.75
0.43
2.25
2014
0.68
0.68
0.47
0.39
2.22
2013
1.42
1.12
1.11
0.65
4.30
2012
0.91
0.83
1.18
0.72
3.64
2011
0.95
1.07
1.11
0.77
3.90
2010
1.13
1.22
1.18
1.05
4.58
2009
1.2
1.06
0.86
0.83
3.95
2008
0.97
0.88
-0.43
-3.31
-1.89
2007
0.47
0.61
0.85
0.78
2.71
2006
0.77
0.76
0.8
0.12
2.45
2005
0.68
-0.23
0.73
0.65
1.83
2004
0.37
0.61
0.7
-0.0022
1.68
2003
0.38
0.64
0.66
0.69
2.37
2002
0.58
0.61
0.64
0.69
2.52
2001
0.75
0.77
0.53
0.53
2.58
2000
0.78
0.62
0.72
0.71
2.83
1999
0.57
0.53
0.68
0.73
2.51
1998
0.47
0.45
0.47
0.52
1.91
1997
0.39
-1.57
0.41
0.42
-0.35
1996
0.36
0.31
0.38
0.34
1.39
1995
0.35
0.29
1.08
0.31
2.03
1994
0.29
0.3
0.28
0.25
1.12
1993
0.31
0.3
0.25
-0.44
0.42
1992
0.38
0.29
-0.23
0.27
0.71
1991
0.34
0.27
0.26
0.27
1.14
1990
0.29
0.24
0.23
0.23
0.99
1989
0.25
0.19
0.19
0.2
0.83
1988
0.21
0.16
0.15
0.16
0.68
1987
0.18
0.13
0.13
0.13
0.57
1986
0.16
0.12
0.13
0.12
0.53
1985
-
-
0.11
0.12
0.23
Brief information
Eli Lilly and Company (LLY) stock split history
Understanding the historical stock splits of Eli Lilly and Company (LLY) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on October 16, 1997 with a ratio of 2:1. Throughout its history, the company has undergone 4 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
